Doisynoestrol

Doisynoestrol (brand names Fenocyclin, Surestrine, Surestryl; former developmental code name RS-2874), also known as fenocycline, as well as cis-bisdehydrodoisynolic acid 7-methyl ether (BDDA ME), is a synthetic nonsteroidal estrogen of the doisynolic acid group that is no longer marketed.[1][2] It is a methyl ether of bisdehydrodoisynolic acid.[1] Doisynoestrol was described in the literature in 1945.[1]

Doisynoestrol
Clinical data
Trade namesFenocyclin, Surestrine, Surestryl
Other namesDiosynestrol; Fenocycline; Fenocyclin; Phenocyclin; RS-2874; Dehydrofolliculinic acid; cis-Bisdehydrodoisynolic acid 7-methyl ether; BDDA ME;
Routes of
administration
By mouth
Drug classNonsteroidal estrogen
Identifiers
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC19H22O3
Molar mass298.382 g·mol−1
3D model (JSmol)

See also

References

  1. J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 465–. ISBN 978-1-4757-2085-3.
  2. Herbai, G. (1971). "SEPARATION OF GROWTH INHIBITING POTENCY FROM OESTROGENICITY IN DIFFERENT WEAK OESTROGENIC DRUGS OF VARIOUS CHEMICAL STRUCTURES". European Journal of Endocrinology. 68 (2): 249–263. doi:10.1530/acta.0.0680249. ISSN 0804-4643.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.